Sumitomo Chemical raises FY2025 earnings forecast on strong performance
Sumitomo Chemical (TSE:4005) announced an upward revision to its consolidated earnings forecast for the fiscal year ending March 31, 2025. The company now expects sales revenue of JPY 2,606,000 million, up from the previous forecast of JPY 2,600,000 million. The core operating profit forecast has been significantly raised from JPY 100,000 million to JPY 140,000 million, while operating profit is now projected at JPY 193,000 million, up from JPY 180,000 million. The net profit attributable to owners of the parent is expected to reach JPY 38,000 million, a substantial increase from the initial forecast of JPY 25,000 million. The revision is attributed to strong sales in Sumitomo Pharma, particularly for Orgovyx in North America, and increased shipments of display-related materials in the ICT & Mobility Solutions segment, combined with successful performance improvement measures across all segments.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Sumitomo Chemical publishes news
Free account required • Unsubscribe anytime